CONVERSION FROM TWICE TO ONCE DAILY MELTDOSE TACROLIMUS FORMULATION IN STABLE KIDNEY TRANSPLANT RECIPIENTS: PHARMACOKINETICS (PK) IN LOW TROUGH PATIENTS

被引：0
|
作者：
Malvezzi, Paolo [1 ]
Stevens, Daniel [2 ]
Du, Wei [3 ]
Procaccianti, Claudio [4 ]
Rostaing, Lionel [1 ]
机构：
[1] Chu Grenoble Alpes, Serv Nephrol Hemodialyse Aphereses & Transplantat, La Tronche, France
[2] Veloxis Pharmaceut, Cary, NC USA
[3] Clin Stat Consulting, Cardiff By The Sea, CA USA
[4] Chiesi Farmaceut SPA, Parma, Italy
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
BOS439
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [31] ONCE-DAILY MELTDOSE TACROLIMUS FORMULATION IN KIDNEY TRANSPLANT RECIPIENTS: EVALUATION OF RENAL FUNCTION IN CAUCASIAN FAST TACROLIMUS METABOLIZERS
    Suwelack, Barbara
    Bunnapradist, Suphamai
    Stevens, Daniel
    Du, Wei
    Procaccianti, Claudio
    Maas, Christoph
    Budde, Klemens
    TRANSPLANT INTERNATIONAL, 2017, 30 : 561 - 561
  • [32] RENAL FUNCTION AND SAFETY IN STABLE KIDNEY RECIPIENTS CONVERTED FROM TACROLIMUS TWICE DAILY TO A ONCE-DAILY FORMULATION
    Kraemer, B.
    Morales, J.
    Lauzurica, R.
    van Hooff, J. P.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 8 - 8
  • [33] Renal Function and Safety in Stable Kidney Recipients Converted from Tacrolimus Twice Daily to a Once-Daily Formulation
    Morales, J.
    Lauzurica, R.
    van Hooff, J. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 512 - 512
  • [34] CONVERSION FROM TWICE DAILY TACROLIMUS TO ONCE DAILY MODIFIED RELEASE TACROLIMUS IN STABLE PANCREAS TRANSPLANT RECIPIENTS - A SAFETY STUDY.
    Laurence, Jerome
    Dib, Martin J.
    Barbas, Andrew S.
    Marquez, Max A.
    Sapisochin, Gonzalo
    Norgate, Andrea
    Schiff, Jeffrey
    McGilvray, Ian D.
    Selzner, Markus
    Greig, Paul D.
    Cattral, Mark S.
    TRANSPLANTATION, 2015, 99 (11) : S50 - S50
  • [35] Single Center Experiences of Conversion from Twice-daily Tacrolimus To Once-Daily Tacrolimus in Stable Liver Transplant Recipients
    Kim, Tae-Seok
    Ahn, Keun Soo
    Kim, Yong Hoon
    Kim, Hyoung Tae
    Kang, Koo Jeong
    TRANSPLANTATION, 2015, 99 : 213 - 214
  • [36] Conversion of Stable Kidney Transplant Recipients From a Twice-Daily to Once-Daily Everolimus Regimen
    Carmellini, M.
    Collini, A.
    Ruggieri, G.
    Bernini, M.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (04) : 1312 - 1313
  • [37] Pharmacokinetics in Stable Kidney Transplant Recipients After Conversion From Twice-Daily to Once-daily Tacrolimus Formulations: Erratum (vol 34, pg 46, 2012)
    van, Hooff J.
    Van der Walt, I
    Kallmeyer, J.
    THERAPEUTIC DRUG MONITORING, 2012, 34 (04) : 486 - 486
  • [38] Safety and Efficacy of Conversion from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Graceptor) in Stable Kidney Transplant Recipients
    Nakamura, Y.
    Hama, K.
    Katayama, H.
    Soga, A.
    Toraishi, T.
    Yokoyama, T.
    Kihara, Y.
    Jojima, Y.
    Konno, O.
    Iwamoto, H.
    Takeuchi, H.
    Hirano, T.
    Shimazu, M.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (01) : 124 - 127
  • [39] Conversion of stable pediatric liver transplant recipients from twice daily prograf to once daily modified release tacrolimus.
    Heffron, TG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 511 - 511
  • [40] EFFECT OF CONVERSION FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS ON GLUCOSE INTOLERANCE IN STABLE KIDNEY TRANSPLANT RECIPIENTS - EVALUATION AT 12 MONTHS
    Ito, Shinichi
    Tsuchiya, Tomohiro
    Nagai, Shingo
    Deguchi, Takashi
    TRANSPLANT INTERNATIONAL, 2013, 26 : 90 - 90
12345